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INTRODUCTION:  Adult  hepatoblastoma  is a  rare  malignant  liver  neoplasm.  Surgery  is  the  only  cure, but
recurrence  is  common  even  after  complete  resection.  No therapeutic  strategy  has  been  established.
PRESENTATION OF  CASE:  A  22-year-old  man  presented  with  a rapidly  expanding  right  hypochondrial  mass.
Pain  preceded  the  appearance  of the  mass.  No  deﬁnitive  diagnosis  was  established  in  the  referring  hospi-
tal.  In addition,  two  attempts  of  embolization  failed  to reach  the  tumor  due  to its large  size  and  vascular
displacement.  Clinical  examination  revealed  a 26 cm  ×23 cm  mass  occupying  the  right hypochondrium
and  epigastrium  as  far as  the  right  iliac  fossa,  compressing  the  stomach,  spleen,  kidneys  and  liver.  The
preoperative  diagnosis  was  gastrointestinal  stromal  tumor  because  it appeared  to  originate  from  the
stomach.  During  surgery,  we found  a mass  arising  from  the  liver,  adhering  to the omentum,  stomach,  and
left  hemidiaphragm,  and inﬁltrating  the  pericardium.  The  tumor  was  completely  resected  off the  inferior
vena  cava  and  pericardium.  The  histopathological  diagnosis  was  a 30 cm ×  30  cm  hepatoblastoma  weigh-
ing  4 kg.  The  postoperative  treatment  course  went  smoothly  until  day  10,  when  the  patient  developed
complications  like bilateral  atrial  thrombi  and  left ventricular  hypokinesia  and  expired  on day  16.
DISCUSSION: Due to the  rarity  of hepatoblastoma  in  adults  and  non-speciﬁc  initial  symptoms,  hepa-
toblastoma  is  often  overlooked  as  a diagnosis.  Early  detection  may  lead  to  improved  prognosis  and
survival.
CONCLUSION:  We  report  here  the  ﬁrst case  of  adult  hepatoblastoma  in  the  Middle  East  and the largest
such  tumor  ever  reported  in  literature.
gical © 2012 Sur
. Introduction
Hepatoblastoma is the most common liver tumor in children
nder the age of 2 years.1 Reports of adult cases are extremely rare.
ost of these tumors arise in the embryo during liver develop-
ent and have embryonic features such as numerous mitoses,2 and
ften present with ribbon-like or papillary formations. In adults,
he prognosis is extremely poor. Although surgery offers the only
hance for cure, it often recurs even after complete resection, and
o therapeutic strategies have yet been established because of its
arity.3,4 A review by Zheng et al.3 reports only 15 cases in the
nglish literature, where nine cases were treated by surgery, two
y surgery followed by chemotherapy and one by chemoemboliza-
ion; however, they all had a very poor prognosis. In another more
ecent review, Rougemont et al.4 described a total of 45 cases of
dult hepatoblastoma, all with very dismal prognosis due to late
resentation and with no consensus on the treatment due to the
arity of the disease. Most of these patients expired before surgery
r soon after surgery. We  present the ﬁrst case of adult hepatoblas-
oma reported in the Middle East.
∗ Correspondence address: Department of Surgery, College of Medicine and Med-
cal Sciences, Taif University, PO Box 888, Taif 21947, Kingdom of Saudi Arabia.
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2. Presentation of case
2.1.  Presentation
Our patient was an otherwise healthy 22-year-old Saudi male
who was referred to us from another hospital. He had a large and
expanding abdominal mass that had been palpable for 6 months.
The patient initially presented with dull aching epigastric and right
upper quadrant abdominal pain. The referring hospital did not diag-
nose the condition, but had attempted embolization with stainless
steel coils to reduce the vascularity and size of the mass; however,
they failed due to the large size of the tumor and vascular displace-
ment. They attempted to go through both the left gastric and the
hepatic artery. Upon examination, a large, palpable mass extend-
ing from the right hypochondrium and epigastric region to the right
iliac fossa was  found. There was no lymphadenopathy, and systemic
examination showed normal results.
2.2. Laboratory investigations
Open access under CC BY-NC-ND license. In  our hospital, CBC, LFTs, lipase, and amylase levels, and the
results of renal panel were normal. The tumor markers present
were CEA (<0.5 ng/mL) and AFP (1.3 ng/mL). Tests for hepatitis
markers (B & C) were negative.
NC-ND license. 
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lFig. 1. Large mass seen in the upper abdomen.
.3. Radiological investigations
Abdominal  ultrasonography revealed a hypoechoic lesion
n the epigastric region adjacent to the left liver measur-
ng 24.7 cm ×12.8 cm.  Contrast-enhanced abdominal computed
omography showed a very large heterogeneous mass of about
6 cm × 23 cm occupying the anterior part of the abdomen, caus-
ng compression of the stomach and shifting of the liver, spleen and
oth kidneys posteriorly (Fig. 1). Inﬁltration of the diaphragm and
he pericardium (Fig. 2) was observed, but there was  no free ﬂuid.
he initial diagnosis was a gastrointestinal stromal tumor (GIST) or
eritoneal mesothelioma because of its proximity and suspected
rigin from the stomach. Further, the tumor was  not suspected to
ave originated from the liver because of its large size and loca-
ion, the displacement of all the organs in the upper abdomen, and
ormal liver function test.
ig. 2. The mass inﬁltrating the pericardium and compressing the liver, spleen and
eft kidney.PEN  ACCESS
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2.4. Operative ﬁndings
We  decided to conduct exploratory laparotomy and possible
resection of the tumor. After discussion with the patient and
his family on the risks of the procedures, informed consent was
obtained. A midline incision revealed a large mass that was adher-
ent to the omentum, pushing the bowel downward, the liver
and spleen laterally, and the stomach and pancreas posteriorly. It
extended to the chest and involved the left hemidiaphragm and
the pericardial space. The mass was mobilized with good hemosta-
sis. Initially, we thought that it originated from the stomach, so
we opened the stomach and found that the only structure adher-
ent to the stomach was the tumor capsule. Dissection of the mass
showed that it originated from the left hemiliver and was  push-
ing on the pericardium and diaphragm. Exposure of the heart via
median sternotomy resulted in a gush of ﬂuid from the pericar-
dial space. En-block excision of the tumor was  performed using
a piece of the diaphragm, and a left hepatic lobectomy was  per-
formed. The tumor was found to involve a part of the inferior vena
cava (IVC), just inferior to the diaphragm. The tumor was shaved
from the inferior vena cava, and the entire mass was excised and
sent for histopathological examination. The sternotomy wound was
closed and good hemostasis was  maintained in the chest. At this
point the patient became hypotensive and began to bleed because
of coagulopathy from the long procedure and acidosis, where he
was transfused 11 Units of PRBC and 8 Units of FFP. A decision was
made to pack all the areas around the liver and spleen, and the
abdomen was closed.
2.5.  Postoperative care
The  patient was transferred to the ICU and his condition sta-
bilized. After 2 days, he was  taken back to the OR for removal of
the packs and to ensure hemostasis. Upon opening the abdominal
wound and removing the packs, we observed a collected hematoma
over the liver bed and a second laceration bleeding from the upper
surface of the right hepatic lobe. This was managed and controlled
with Surgicel. Two drains were inserted and hemostasis was main-
tained. The abdomen was  closed in layers and the patient was
transferred to the ICU in good condition. The patient was extu-
bated after 2 days and was stable hemodynamically for 6 days,
but on the following 7th day, he had hemodynamic ﬂuctuations
that required him to be re-intubated. An echocardiogram revealed
a bilateral atrial thrombus with left ventricular global hypokine-
sia. The patient coagulation proﬁle deteriorated with a drop in
hemoglobin level despite massive transfusions. The patient devel-
oped sepsis which led to acute renal shutdown. We  found that
the source of sepsis was Acinetobacter which was detected in the
patient sputum and blood culture that could have caused the atrial
thrombus. All resuscitation measures were carried out, but the
patient showed no signs of improvement, continued bleeding from
all drains, and died shortly thereafter on day 16.
2.6. Final pathology report
The  ﬁnal pathology report was  a 30 cm ×30 cm mixed
hepatoblastoma weighing 4 kg (Fig. 3) with positive immunohis-
tochemistry results for vimentin, focal alpha-fetoprotein and CEA
(Figs. 4).
3.  DiscussionHepatoblastoma is the most common primary malignant liver
neoplasm in children,1 and approximately 90% of all hepatoblas-
toma cases occur in patients under 5 years of age.2 Boys are affected
at twice the rate compared to girls.5 Hepatoblastoma in adolescent
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nd young adults is extremely rare, with only 45 cases reported in
iterature,4 and the prognosis is much worse than that in childhood
ases because they are usually diagnosed late.5 Studies on hepato-
lastoma in adults have revealed a slight female preponderance.
he age of patients reported in the literature range from 17 to 82.6
n our case, the patient was a 22-year-old man.
The etiology of hepatoblastoma has been elusive, but cytoge-
etic and molecular genetic abnormalities in hepatoblastoma have
evealed involvement of chromosomal loci on 1q, 2 (or 2q), 4q, 8
or 8q), and 20.7 Loss of heterozygosity and imprinting at locus 11p
5.5 is also suggested to be a genetic basis for hepatoblastoma.7
ccumulation of nuclear -catenin implies oncogenic alteration
f the WNT/-catenin pathway. Nuclear p53 accumulation indi-
ates that a p53 mutation is also involved in the pathogenesis
Fig. 4. HB with Alfa-fetoprotien-positive staining.PEN  ACCESS
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of hepatoblastoma.8 Hepatoblastoma is believed to arise from a
hepatic blastema, but this hypothesis seems to be inapplicable
to adult-onset hepatoblastoma. Patients more than 70 years old
have been diagnosed with hepatoblastoma, and the persistence of
primitive hepatic blastema for such a long period seems unlikely.
Furthermore, liver cirrhosis is not seen in childhood hepatoblas-
toma patients but is associated with 30% of adult hepatoblastoma
cases.9–11 This implies that these tumors may  develop from differ-
ent pathogenic pathways in adults compared to children.
Tumors mostly occur as a single mass in the right or left liver
(unifocal), or in both livers (multifocal). Only one multifocal case
has been reported so far.12,13 The sizes of reported tumors range
from 2.5 to 25 cm.  The tumor in our patient arose from the left
liver, was  unifocal, and measured 30 cm × 30 cm.
The  usual presentation of hepatoblastoma is loss of energy, loss
of weight, and a rapidly enlarging upper abdominal mass. Some
patients present with pain, fever and vomiting.12,13 In our patient,
the ﬁrst indication was upper abdominal pain, followed by a rapidly
enlarging mass.
The  initial diagnosis of HB is mainly based on imaging. Proper
diagnosis, staging and treatment of HB require accurate imaging
studies. In this particular case the tumor was large, originated from
the periphery of the left liver, and displaced all the upper abdominal
organs, which made the diagnosis somewhat difﬁcult. Ultrasono-
graphy is non-invasive and is particularly useful for examining
infants; the tumor is seen as a hyperechoic, solid, intrahepatic
mass.14 Other standard methods include computed tomography,
magnetic resonance imaging, and measurement of serum AFP and
-HCG levels. However, ﬁnal diagnosis relies on tumor biopsy. Hep-
atoblastoma is extremely rare in adults, and the initial symptoms
are non-speciﬁc because of which it is often overlooked. Diagnosis
of adult hepatoblastoma is also complicated by its similarities to
other types of tumors such as hepatic teratoma, carcinosarcoma,
malignant mesenchymal tumor and hepatocellular carcinoma, and
preoperative needle biopsy is contraindicated by nearly all authors
if the surgeon is attempting surgical resection.12 One  could argue
that the use of transhepatic biopsy in this case, followed by neoad-
juvant therapy could have helped in decreasing the tumor bulk.
However, because of bleeding (vascular tumor as seen on CT), the
fear of rupture (large size) and our belief that the tumor could be
excised completely, in addition to other reasons mentioned above,
transhepatic biopsy was not done.
Thus, diagnosis of hepatoblastoma is not made until tumor
biopsy or autopsy. The usual pre-operative diagnosis is hepato-
cellular carcinoma, hepatic amoebic abscess or even abdominal
aortic aneurysm13 and in the present case the preoperative diag-
nosis was  GIST. AFP and CEA were not detected and biopsy was  not
done because of the fear of spread and rupture of the tumor; also,
with the diagnosis of GIST or sarcoma usually biopsy is contraindi-
cated. Hepatoblastoma could be suspected in middle aged patients
presenting with a primary liver lesion that is large in size and not
showing any risk factors for hepatocellular carcinoma like hepati-
tis. On the contrary, primary liver tumor is rarely seen in young
adults without hepatitis. In this case the tumor was very large and
we did not know its origin otherwise we would have suspected
hepatoblastoma, as we have mentioned above. This is the reason
why other diagnosis was  made.
Complete surgical resection is the primary treatment for
patients with hepatoblastoma and is the only chance for opti-
mal clinical outcome. Despite this, improvements in survival
have occurred over the last three decades due to chemother-
apy regimens that reduce tumor size and enable complete tumor
excision even for initially unresectable or metastatic disease.15,16Chemotherapy not only shrinks tumors, but also makes them less
prone to bleeding and delineates them from the surrounding tis-
sues to facilitate their resection. Hepatoblastoma is sensitive to
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hemotherapeutic agents such as doxorubicin, cisplatin, vin-
ristine, 5-FU and cyclophosphamide.17 In the present case, the
umor was at an advanced stage, but was completely resected
xcept for a thin layer that was adherent to the inferior vena
ava. Unfortunately the patient died before receiving chemother-
py.Liver transplantation has shown promise in the treatment of
hildren with unresectable hepatic tumors, and post-transplant
urvival rates as high as 80% have been reported for children
ith hepatoblastoma.18 The current 5-year survival rate in chil-
ren is 75% compared with only 35% almost 30 years ago.19 Due to
ack of experience in transplants in adult patients, it is reasonable
o select radical resection and chemotherapy for hepatoblastoma
n adults.18 Despite the progress in therapy, 20–30% of pediatric
atients of HB die. In adults, the reported cases survived for only 2
eeks to 38 months (median survival duration, 6 months), which
s signiﬁcantly lower than that for children.15,16
. Conclusion
The low incidence of hepatoblastoma in adults and non-speciﬁc
nitial symptoms make the diagnosis difﬁcult, and patients may
resent at a late stage of the disease, with increased mortality rates.
his represents a diagnostic challenge because prognosis could be
mproved with early detection.
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